Scientific Comment
Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome
Lido
1375
Vezesque se leu este artigo
525
Total PDF
850
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 7 | 47 | 31 | 78 |
| 2025 6 | 53 | 16 | 69 |
| 2025 5 | 59 | 15 | 74 |
| 2025 4 | 26 | 11 | 37 |
| 2025 3 | 56 | 13 | 69 |
| 2025 2 | 38 | 23 | 61 |
| 2025 1 | 26 | 20 | 46 |
| 2024 12 | 27 | 16 | 43 |
| 2024 11 | 19 | 19 | 38 |
| 2024 10 | 31 | 14 | 45 |
| 2024 9 | 28 | 19 | 47 |
| 2024 8 | 40 | 29 | 69 |
| 2024 7 | 19 | 12 | 31 |
| 2024 6 | 34 | 31 | 65 |
| 2024 5 | 35 | 20 | 55 |
| 2024 4 | 31 | 12 | 43 |
| 2024 3 | 34 | 25 | 59 |
| 2024 2 | 27 | 25 | 52 |
| 2024 1 | 26 | 16 | 42 |
| 2023 12 | 17 | 19 | 36 |
| 2023 11 | 28 | 30 | 58 |
| 2023 10 | 18 | 26 | 44 |
| 2023 9 | 25 | 28 | 53 |
| 2023 8 | 16 | 13 | 29 |
| 2023 7 | 32 | 7 | 39 |
| 2023 6 | 26 | 16 | 42 |
| 2023 5 | 21 | 15 | 36 |
| 2023 4 | 11 | 4 | 15 |
Mostrar tudo
